ADHD in the News 2023-08-31

FDA approves multiple generics of ADHD and BED treatment

Action: FDA has approved several first generics of Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets for attention-deficit/hyperactivity disorder (ADHD) in patients six years and older and moderate to severe binge-eating disorder (BED) in adults. See Vyvanse’s prescribing information for details on dosing.

The 10 Unexpected ADHD Signs Most People Miss, According to Psychologists

Picture this. Over the years, you’ve been to multiple mental health professionals as you try to arrive at a diagnosis, presenting a set of symptoms that can be seen among several disorders, like anxiety, irritability and mood swings. You’ve always been a great student, and as an adult, you’re pretty organized and on top of things. So, it couldn’t be ADHD (Attention Deficit Hyperactivity Disorder)…right?

The ADHD drug market is already stretched thin. Now it’s facing a back-to-school supply strain

KEY POINTS: It’s been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — and the supply strain could potentially worsen in the months ahead. Some experts noted they’re concerned about market conditions as children, who are commonly affected by ADHD, head back to school. It’s nearly impossible to know when the shortages will end — or what exactly can be done to resolve them — because of the lack of transparency in the pharmaceutical industry.

Underutilized antidepressant treatment for postnatal depression associated with improved child outcomes at age five

[Excerpt] The study, published in JAMA Network Open, found that SSRI treatment for postnatal depression was associated with better outcomes up to five years after childbirth than mothers with postnatal depression who did not take SSRIs. These included reduced child behavioral difficulties (such as conduct problems and antisocial behavior), child ADHD symptoms and maternal depression, as well as improved satisfaction in partner relationships.

Transcranial magnetic stimulation can treat depression. Developing research suggests it could also help autism, ADHD and OCD

Since the start of the COVID pandemic, there has been more attention given to problems of mental ill-health including depression than ever before. A new therapeutic option, especially for depression, transcranial magnetic stimulation, is slowly helping to address some of these considerable unmet needs in our community.

For Women With Money Issues, an A.D.H.D. Diagnosis Can Be Revelatory

Seven years ago, I wrote an essay about what life would feel like if I didn’t struggle with saving money. In it, I envisioned the power of having enough in emergency funds to tide me over in case I needed to leave an abusive job or relationship.

Pastors with ADHD Can Burn Out or Shine

A swath of energetic, charismatic ministry leaders fight for focus.

Advice on recognizing and dealing with ADHD in students

The transition from summer fun to a more structured classroom schedule can be tough for some kids and can reveals symptoms of ADHD that need to be addressed, Allina Health child and teen Psychologist Dr. Clinten Vanlith explains.

The Children in ‘The Medicated Child’ Have Grown Up, and Mental Health Treatment for Kids Has Evolved

When Jessica Kennedy was five years old, she was diagnosed with bipolar disorder. Her mother told FRONTLINE in the 2008 documentary The Medicated Child that she couldn’t go a day without taking medication to stabilize her mood.

More sleep could reduce impulsive behavior in children

Sleep is a critical part of a child’s overall health, but it can also be an important factor in the way they behave. According to a new study from the Youth Development Institute at University of Georgia, getting enough sleep can help children combat the effects of stressful environments.

Appropriate Use of Stimulant Medications in Adults With ADHD: A Psychiatric Times Custom Video Series

  • EP. 1: Chapter 1. History of Stimulants in ADHD
  • EP. 2: Chapter 2. Guidance and Recommendations for the use of Stimulants in Adults With ADHD
  • EP. 3: Chapter 3. Pharmacokinetic Profiles of Long-Acting Stimulants
  • EP. 4: Chapter 4. Optimal Treatment Outcomes for Treating Patients With ADHD
  • EP. 5: Chapter 5. Adult Perspectives on ADHD Medications
  • EP. 6: Chapter 6. Optimizing the Duration of Effect with Stimulant Medications
  • EP. 7: Chapter 7. Stimulant Prescribing Practices for Patients with ADHD
  • EP. 8: Chapter 8. Managing Patient Expectations During Treatment for ADHD

ADHD drug could serve as a cocaine-replacement therapy

Cocaine use continues to be a public health problem, yet despite concerted efforts, no drugs have been approved to resolve cocaine addiction. Research suggests that the attention-deficit/hyperactivity disorder drug methylphenidate (MPH; Ritalin®) could serve as a cocaine-replacement therapy, but clinical results have been mixed.